| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Translational Research Laboratory, Institut Català dOncologia, 08907, L'Hospitalet [M. C., G. C., R. A.], and Department of Biochemistry and Molecular Biology, University of Barcelona 08028 [A. M.], Barcelona, Spain
Adenovirus synthesize proteins that interact with oncogene and tumor suppressor gene products to set the cell for virus replication. Mutant viruses defective in these functions replicate selectively in cancer cells and represent new tools to treat cancer. We report a selectivity strategy based on deletions of adenovirus Virus-Associated (VA) RNAs. In normal cells, these RNAs are necessary for virus replication because they inactivate the RNA-dependent protein kinase protein kinase R, a kinase that otherwise would block protein translation in response to infection. However, downstream effectors of Ras can also inactivate protein kinase R, and therefore, the need for VA RNA genes should be bypassed in cells with an active Ras pathway. We demonstrate here that a VAI RNA mutant presents a Ras-dependent replication and can be used for oncolytic virotherapy of pancreatic tumors.
This article has been cited by other articles:
![]() |
S. M. Battcock, T. W. Collier, D. Zu, and K. Hirasawa Negative Regulation of the Alpha Interferon-Induced Antiviral Response by the Ras/Raf/MEK Pathway J. Virol., May 1, 2006; 80(9): 4422 - 4430. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Aparicio, N. Razquin, M. Zaratiegui, I. Narvaiza, and P. Fortes Adenovirus Virus-Associated RNA Is Processed to Functional Interfering RNAs Involved in Virus Production J. Virol., February 1, 2006; 80(3): 1376 - 1384. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schumann and M. Dobbelstein Adenovirus-Induced Extracellular Signal-Regulated Kinase Phosphorylation during the Late Phase of Infection Enhances Viral Protein Levels and Virus Progeny Cancer Res., February 1, 2006; 66(3): 1282 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, S.-A. Xue, G. Hallden, J. Francis, M. Yuan, B. E. Griffin, and N. R. Lemoine Virus-Associated RNA I-Deleted Adenovirus, a Potential Oncolytic Agent Targeting EBV-Associated Tumors Cancer Res., February 15, 2005; 65(4): 1523 - 1531. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Chu, D. E. Post, F. R. Khuri, and E. G. Van Meir Use of Replicating Oncolytic Adenoviruses in Combination Therapy for Cancer Clin. Cancer Res., August 15, 2004; 10(16): 5299 - 5312. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |